Skip to main content

Blueshift and Althea Receive NHGRI Small Business Grant

NEW YORK (GenomeWeb News) - Blueshift Biotechnologies and Althea Technologies have received an SBIR grant from the National Human Genome Research Institute to combine their products for gene expression profiling, the companies said today.
 
The companies did not disclose the amount of the grant.
The companies will use the grant to combine Blueshift’s high-throughput laser scanner with Althea’s mutiplexed PCR methods to enable quantitative gene expression profiling in a high-thoughput platform.
 
Althea and Blueshift said the integrated platform may generate results for up to 768 samples per minute.
 
Althea CSO Joseph Monforte said in a statement that this capability could "provide an opportunity to broadly introduce gene expression profiling into compound library screening."
 
Monforte said that integrating gene expression with Blueshift’s scanning hardware may offer a system "that delivers quantitative data on dozens of genes in a truly high throughput manner."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.